Rhinocerebral mucormycosis following donor leukocyte infusion: successful treatment with liposomal amphotericin B and surgical debridement

Bone Marrow Transplant. 1998 Oct;22(8):817-8. doi: 10.1038/sj.bmt.1701432.

Abstract

A 24-year-old male developed cytogenetic relapse of chronic myeloid leukemia (CML) four years after allogeneic BMT. After a year of treatment with IFN-alpha, he achieved a partial cytogenetic response. Treatment with donor leukocyte infusions (DLI) was given (total dose 1 x 10(8) T lymphocytes/kg). Two months later, he developed acute GVHD (skin and liver), that improved with CsA and methylprednisolone and resulted in cytogenetic remission with complete donor chimerism. One month later he developed rhinocerebral mucormycosis and was successfully treated with surgical debridement and liposomal amphotericin B (total dose 12 g). This is the first case of mucormycosis described after DLI.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphotericin B / therapeutic use*
  • Antifungal Agents / therapeutic use*
  • Brain Diseases / drug therapy
  • Brain Diseases / etiology
  • Brain Diseases / microbiology
  • Brain Diseases / surgery
  • Drug Carriers
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Leukocyte Transfusion / adverse effects*
  • Liposomes
  • Male
  • Mucormycosis* / drug therapy
  • Mucormycosis* / etiology
  • Mucormycosis* / surgery
  • Transplantation, Homologous

Substances

  • Antifungal Agents
  • Drug Carriers
  • Liposomes
  • Amphotericin B